Market Trends of Dental Biomaterials Industry
This section covers the major market trends shaping the Dental Biomaterials Market according to our research experts:
Titanium Biomaterials Segment is Expected to Witness Considerable Growth over the Forecast Period
Titanium biomaterials are a central class of materials for use in dental treatments. This can be attributed to the high strength and other mechanical properties associated with this material. Currently, biomaterials are made up of metals and alloys, polymers, ceramics, and composites. Among them, implanted materials made up of titanium are regarded as the most useful medical devices. Titanium is considered inert and safe for human use. It causes minimal side effects in the human body. Thus, owing to such advantages, titanium biomaterials are widely used as metallic biomaterials for dental procedures.
The advantages of titanium biomaterials and increasing dental visits are the major drivers for the segment. For instance, according to the research article published in November 2021, titanium alloys are widely used for dental and implant materials due to their superior biocompatibility, corrosion resistance, and mechanical strength compared with other metallic and non-metalic implant materials. Similarly, as per the article published in August 2021, Ti-Ga-Si is considered to combine the advantages of the Ti-Ga alloy along with Si, which enhances osseointegration with aesthetically pleasing outcomes for patients and minimal likelihood of medical complications. Furthermore, according to an NCBI study published in June 2021, the alloys cpTi and Ti-6Al-4V are highly satisfactory materials and should be used for dental implants. Such studies indicate the efficacy of titanium biomaterials and are expected to generate significant demand for titanium biomaterials, thus positively impacting the segment's growth. The product launches by the key players are also expected to create opportunities for segment growth. For instance, in July 2021, NuVasive launched Modulus ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions. Therefore, owing to the advantages of titanium biomaterials, product launches by key players, and increasing dental visits, considerable segment growth is anticipated over the forecast period.
North America is Expected to Witness Significant Growth Over the Forecast Period
North America is expected to witness considerable growth over the forecast period. The growth is due to the factors such as the increase in product launches supported by government authorities, the rising burden of dental diseases, and the increasing geriatric population bolstering the demand for dental biomaterials in the region. For instance, as per the American Dental Association, in 2021, more than 5.0 million seniors aged 65 to 74 in the United States had complete tooth loss, with nearly 3.0 million suffering from edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly population. This is because 91.0% of adults aged 20 to 64 have dental caries, with a staggering 27.0% going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. Thus, such factors are anticipated to boost the total dental procedures performed across North America, thereby boosting the demand for dental biomaterials within the region.
Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing dental visits in the United States are some of the factors driving the growth of the dental biomaterials market in the country. Furthermore, several market players are also engaged in implementing strategic initiatives, thereby propelling market growth. For instance, in January 2020, Pulpdent Corporation, a dental research, and manufacturing company based in the Greater Boston area, launched its ACTIVA Presto dental material. The new white dental filling material mimics the properties of natural teeth. Similarly, in September 2020, Ditron Dental USA, the United States affiliate of Ditron Dental, started its commercial operations for its dental implant portfolio in the country. Therefore, owing to the product launches in the country the market is expected to witness significant growth over the forecast period.
